An observational study in Adenomyosis and Abnormal Uterine Bleeding, sponsored by University of Texas Southwestern Medical Center. Withdrawn. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2021-02-02.
Sponsored by University of Texas Southwestern Medical Center · Observational
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
142 studies on the registry are indexed under Adenomyosis; 54 are open to participants now.
Browse Adenomyosis studies →University of Texas Southwestern Medical Center is the lead sponsor of 1,010 studies on the registry; 199 are open to participants now.
Of its 139 completed or terminated interventional studies of FDA-regulated products, 105 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women with abnormal uterine bleeding due to adenomyosis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Levnorgestrel containing IUD
Also known as: Mirena
Menstrual blood loss
Pictorial blood loss assessment chart
Time frame: 12 months
Quality of Life
SF-12
Time frame: 12 months
Pain
Visual analog scale
Time frame: 12 months
No study locations are listed for this record.
Start is estimated for Dec 2020; primary completion for Oct 2022, 22 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Texas Southwestern Medical Center →